News - Press Releases & Updates About Saladax Biomedical

General News

Oncology News

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test

General News

Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…

John BuckleyMarch 15, 2022

General News

CEO Sal Salamone Honored with International Award for his Work in the Life Sciences

Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…

John BuckleyNovember 30, 2021

General News

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…

John BuckleyNovember 22, 2021

General News

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award

BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…

John BuckleySeptember 27, 2021

Psychiatry News

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…

John BuckleyFebruary 17, 2021

Psychiatry News

Saladax Biomedical Launches Clozapine Test in the US After FDA Grants Market Authorization

Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…

John BuckleyJuly 8, 2020

Psychiatry News

HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents

The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…

John BuckleyJune 27, 2020

Oncology News

Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally

Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…

John BuckleyMay 4, 2020

Psychiatry News

Studies Feature Clinical Validations of Clozapine Point-of-Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients with Schizophrenia.

View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…

John BuckleyOctober 24, 2019

Psychiatry News

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia

Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…

John BuckleySeptember 5, 2019

Saladax Connects with Pharmacy Leaders at the Arizona Pharmacy Association Annual Convention 2026

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test

Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests

CEO Sal Salamone Honored with International Award for his Work in the Life Sciences

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay

Saladax Biomedical Launches Clozapine Test in the US After FDA Grants Market Authorization

HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents

Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally

Studies Feature Clinical Validations of Clozapine Point-of-Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients with Schizophrenia.

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia

BCI Region Popup

BCI Region Popup Update